Pegloticase Treatment Significantly Decreases Blood Pressure in Patients With Chronic Gout. [electronic resource]
Producer: 20191119Description: 95-101 p. digitalISSN:- 1524-4563
- Adult
- Aged
- Blood Pressure Determination -- methods
- Chronic Disease
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Gout -- complications
- Gout Suppressants -- therapeutic use
- Humans
- Hypertension -- etiology
- Kidney Function Tests
- Linear Models
- Male
- Middle Aged
- Polyethylene Glycols -- therapeutic use
- Prognosis
- Propensity Score
- Randomized Controlled Trials as Topic
- Risk Assessment
- Treatment Outcome
- Urate Oxidase -- therapeutic use
- Uric Acid -- blood
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.